Paper36768491
Impact of the TRPV2 Inhibitor on Advanced Heart Failure in Patients with Muscular Dystrophy: Exploratory Study of Biomarkers Related to the Efficacy of Tranilast.
Takahashi C and 4 others. Int J Mol Sci, 2023. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Impact of the TRPV2 Inhibitor on Advanced Heart Failure in Patients with Muscular Dystrophy: Exploratory Study of Biomarkers Related to the Efficacy of Tranilast. Papers, record 36768491. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36768491
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Impact of the TRPV2 Inhibitor on Advanced Heart Failure in Patients with Muscular Dystrophy: Exploratory Study of Biomarkers Related to the Efficacy of Tranilast.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Muscular Dystrophies | Major topic |
| Heart Failure | Major topic |
| Cardiomyopathies | Major topic |
| Humans | |
| ortho-Aminobenzoates | |
| Biomarkers | |
| TRPV Cation Channels |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| H28-NHO(Shinkei)-01 | Grant-in-Aid for Clinical Research from the National Hospital Organization | PubMed |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19050039 | Dominant-negative inhibition of Ca2+ influx via TRPV2 ameliorates muscular dystrophy in animal models. | Hum Mol Genet | 2009 | https://conductscience.org/library/papers/19050039 | PubMed |
| 2 | 30006121 | Urinary prostaglandin metabolites as Duchenne muscular dystrophy progression markers. | Brain Dev | 2018 | https://conductscience.org/library/papers/30006121 | PubMed |
| 3 | 12480795 | Omega-3 fatty acids in inflammation and autoimmune diseases. | J Am Coll Nutr | 2002 | https://conductscience.org/library/papers/12480795 | PubMed |
| 4 | 1282575 | Inhibitory action of tranilast, an anti-allergic drug, on the release of cytokines and PGE2 from human monocytes-macrophages. | Jpn J Pharmacol | 1992 | https://conductscience.org/library/papers/1282575 | PubMed |
| 5 | 31394715 | Blockade of TRPV2 is a Novel Therapy for Cardiomyopathy in Muscular Dystrophy. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31394715 | PubMed |
| 6 | 25988613 | Current understanding of molecular pathology and treatment of cardiomyopathy in duchenne muscular dystrophy. | Molecules | 2015 | https://conductscience.org/library/papers/25988613 | PubMed |
| 7 | 12588785 | Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. | Arterioscler Thromb Vasc Biol | 2003 | https://conductscience.org/library/papers/12588785 | PubMed |
| 8 | 17993463 | Tetranor PGDM, an abundant urinary metabolite reflects biosynthesis of prostaglandin D2 in mice and humans. | J Biol Chem | 2008 | https://conductscience.org/library/papers/17993463 | PubMed |
| 9 | 23603101 | A prostaglandin D2 metabolite is elevated in the urine of Duchenne muscular dystrophy patients and increases further from 8 years old. | Clin Chim Acta | 2013 | https://conductscience.org/library/papers/23603101 | PubMed |
| 10 | 20303788 | Effects of omega-3 polyunsaturated fatty-acid supplementation on redox status in chronic renal failure patients with dyslipidemia. | J Ren Nutr | 2010 | https://conductscience.org/library/papers/20303788 | PubMed |
| 11 | 31896817 | Production of TRPV2-targeting functional antibody ameliorating dilated cardiomyopathy and muscular dystrophy in animal models. | Lab Invest | 2020 | https://conductscience.org/library/papers/31896817 | PubMed |
| 12 | 11133172 | Beneficial effect(s) of n-3 fatty acids in cardiovascular diseases: but, why and how? | Prostaglandins Leukot Essent Fatty Acids | 2000 | https://conductscience.org/library/papers/11133172 | PubMed |
| 13 | 20689756 | Effect of eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signaling in human colorectal cancer cells. | Neoplasia | 2010 | https://conductscience.org/library/papers/20689756 | PubMed |
| 14 | 12469901 | Evidence of increased oxidative stress by simple measurements in patients with dilated cardiomyopathy. | Scand J Clin Lab Invest | 2002 | https://conductscience.org/library/papers/12469901 | PubMed |
| 15 | 16009351 | Protective effects of Ca2+ handling drugs against abnormal Ca2+ homeostasis and cell damage in myopathic skeletal muscle cells. | Biochem Pharmacol | 2005 | https://conductscience.org/library/papers/16009351 | PubMed |
| 16 | 23786999 | Blockade of sarcolemmal TRPV2 accumulation inhibits progression of dilated cardiomyopathy. | Cardiovasc Res | 2013 | https://conductscience.org/library/papers/23786999 | PubMed |
| 17 | 14698037 | COX-2-mediated PGD2 synthesis regulates phosphatidylcholine biosynthesis in rat renal papillary tissue. | Biochem Pharmacol | 2004 | https://conductscience.org/library/papers/14698037 | PubMed |
| 18 | 19474179 | omega-3 polyunsaturated fatty acid supplementation for the treatment of heart failure: mechanisms and clinical potential. | Cardiovasc Res | 2009 | https://conductscience.org/library/papers/19474179 | PubMed |
| 19 | 21561620 | Effect of n-3 fatty acids and statins on oxidative stress in statin-treated hypercholestorelemic and normocholesterolemic women. | Atherosclerosis | 2011 | https://conductscience.org/library/papers/21561620 | PubMed |
| 20 | 23188550 | Cyclooxygenase-2 expression in skeletal muscle of knockout mice suffering Duchenne muscular dystrophy. | Histochem Cell Biol | 2013 | https://conductscience.org/library/papers/23188550 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41511297 | Tranilast Does Not Inhibit TRPV2. | Cells | 2025 | https://conductscience.org/library/papers/41511297 | PubMed |
| 40011677 | Urinary prostaglandin D2 and E2 metabolites are elevated with disease severity in patients with Fukuyama congenital muscular dystrophy. | Sci Rep | 2025 | https://conductscience.org/library/papers/40011677 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FAS | 355 | PubTator's text mining | https://conductscience.org/library/genes/355 | NCBI Gene |
| NPPB | 4879 | PubTator's text mining | https://conductscience.org/library/genes/4879 | NCBI Gene |
| PTGDS | 5730 | PubTator's text mining | https://conductscience.org/library/genes/5730 | NCBI Gene |
| PTGS2 | 5743 | PubTator's text mining | https://conductscience.org/library/genes/5743 | NCBI Gene |
| TRPV2 | 51393 | PubTator's text mining | https://conductscience.org/library/genes/51393 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36768491
GET https://conductscience.org/api/papers/v1/36768491/references?page=2